Anti-inflammatory Agents: Present and Future

Overview

Journal Cell

Publisher Cell Press

Specialty Cell Biology

Date 2010 Mar 23

PMID 20303881

Citations 393

Authors

Charles A Dinarello

Affiliations

Soon will be listed here.

Abstract

Inflammation involving the innate and adaptive immune systems is a normal response to infection. However, when allowed to continue unchecked, inflammation may result in autoimmune or autoinflammatory disorders, neurodegenerative disease, or cancer. A variety of safe and effective anti-inflammatory agents are available, including aspirin and other nonsteroidal anti-inflammatories, with many more drugs under development. In particular, the new era of anti-inflammatory agents includes "biologicals" such as anticytokine therapies and small molecules that block the activity of kinases. Other anti-inflammatories currently in use or under development include statins, histone deacetylase inhibitors, PPAR agonists, and small RNAs. This Review discusses the current status of anti-inflammatory drug research and the development of new anti-inflammatory therapeutics.

Citing Articles

Role of RGS17 in cisplatin-induced cochlear inflammation and ototoxicity via caspase-3 activation.

Al Aameri R, Alanisi E, Al Sallami D, Alberts I, Tischkau S, Rybak L Front Immunol. 2025; 16:1470625.

PMID: 40061942 PMC: 11885124. DOI: 10.3389/fimmu.2025.1470625.

In vitro evaluation of the immunomodulatory and antibacterial activities of calcitriol (1,25-dihydroxy-vitamin D3) as a potential application for aerobic vaginitis treatment - preliminary study results.

Tomusiak-Plebanek A, Wiecek G, Golinska E, Strus M BMC Microbiol. 2025; 25(1):29.

PMID: 39825222 PMC: 11740573. DOI: 10.1186/s12866-024-03729-z.

Silk-engineered bioactive nanoparticles for targeted alleviation of acute inflammatory disease via macrophage reprogramming.

Liu R, Zhao E, Wang Y, Zuo H, Li L, Xia Q J Nanobiotechnology. 2025; 23(1):11.

PMID: 39794773 PMC: 11724578. DOI: 10.1186/s12951-024-03055-6.

Anti-Inflammatory Properties of Novel 1,2-Benzothiazine Derivatives and Their Interaction with Phospholipid Model Membranes.

Szczesniak-Siega B, Maniewska J, Wiatrak B, Janek T, Nowotarska P, Czyznikowska Z Membranes (Basel). 2024; 14(12).

PMID: 39728724 PMC: 11678778. DOI: 10.3390/membranes14120274.

Menisoxoisoaporphine A, a novel oxoisoaporphine alkaloid from Menispermi Rhizoma, inhibits inflammation by targeting PDE4B.

Qiao X, Cao X, Xu S, Wang C, Guo R, Yao X Front Pharmacol. 2024; 15:1505116.

PMID: 39691395 PMC: 11649434. DOI: 10.3389/fphar.2024.1505116.

References

Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C, Svenson M, Nielsen J . Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia. 1986; 29(1):63-7. DOI: 10.1007/BF02427283. View

Drenth J, Cuisset L, Grateau G, Vasseur C, De Jong J, Beckmann J . Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet. 1999; 22(2):178-81. DOI: 10.1038/9696. View

Proudfoot A, Power C, Schwarz M . Anti-chemokine small molecule drugs: a promising future?. Expert Opin Investig Drugs. 2010; 19(3):345-55. DOI: 10.1517/13543780903535867. View

Shapiro L, Pott G, Ralston A . Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J. 2001; 15(1):115-122. DOI: 10.1096/fj.00-0311com. View

Reddy S, Jia S, Geoffrey R, Lorier R, Suchi M, Broeckel U . An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med. 2009; 360(23):2438-44. PMC: 2803085. DOI: 10.1056/NEJMoa0809568. View

Hockly E, Richon V, Woodman B, Smith D, Zhou X, Rosa E . Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A. 2003; 100(4):2041-6. PMC: 149955. DOI: 10.1073/pnas.0437870100. View

Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H . Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A. 1999; 96(11):6261-6. PMC: 26869. DOI: 10.1073/pnas.96.11.6261. View

Laliberte R, Eggler J, Gabel C . ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J Biol Chem. 1999; 274(52):36944-51. DOI: 10.1074/jbc.274.52.36944. View

van de Veerdonk F, Lauwerys B, Marijnissen R, Timmermans K, Di Padova F, Koenders M . The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum. 2011; 63(6):1507-16. DOI: 10.1002/art.30314. View

10.

Kuijk L, Beekman J, Koster J, Waterham H, Frenkel J, Coffer P . HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood. 2008; 112(9):3563-73. DOI: 10.1182/blood-2008-03-144667. View

11.

Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S . Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature. 2009; 459(7245):433-6. DOI: 10.1038/nature07965. View

12.

Hoffman H, Throne M, Amar N, Sebai M, Kivitz A, Kavanaugh A . Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 2008; 58(8):2443-52. DOI: 10.1002/art.23687. View

13.

Shein N, Grigoriadis N, Alexandrovich A, Simeonidou C, Lourbopoulos A, Polyzoidou E . Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J. 2009; 23(12):4266-75. PMC: 2812044. DOI: 10.1096/fj.09-134700. View

14.

Susick L, Veluthakal R, Suresh M, Hadden T, Kowluru A . Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. J Cell Mol Med. 2007; 12(5A):1571-83. PMC: 3918073. DOI: 10.1111/j.1582-4934.2007.00171.x. View

15.

Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J . Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005; 201(9):1479-86. PMC: 2213182. DOI: 10.1084/jem.20050473. View

16.

Brough D, Rothwell N . Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J Cell Sci. 2007; 120(Pt 5):772-81. DOI: 10.1242/jcs.03377. View

17.

Garcia-Manero G, Yang H, Bueso-Ramos C, Ferrajoli A, Cortes J, Wierda W . Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood. 2007; 111(3):1060-6. DOI: 10.1182/blood-2007-06-098061. View

18.

Netea M, Nold-Petry C, Nold M, Joosten L, Opitz B, van der Meer J . Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 2008; 113(10):2324-35. PMC: 2652374. DOI: 10.1182/blood-2008-03-146720. View

19.

Goldbach-Mansky R, Dailey N, Canna S, Gelabert A, Jones J, Rubin B . Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006; 355(6):581-92. PMC: 4178954. DOI: 10.1056/NEJMoa055137. View

20.

Stafylas P, Sarafidis P, Lasaridis A . The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality. Int J Cardiol. 2008; 131(3):298-304. DOI: 10.1016/j.ijcard.2008.06.005. View